Evidence map›Paper›PMID 33327602›Full record

ReviewMolecules (Basel, Switzerland)2020

7-Isopentenyloxycoumarin: What Is New across the Last Decade.

Francesca Preziuso, Salvatore Genovese, Lorenzo Marchetti, Majid Sharifi-Rad, Lucia Palumbo, Francesco Epifano, Serena Fiorito

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Francesca PreziusoDepartment of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti Scalo (CH), Italy.
Salvatore GenoveseDepartment of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti Scalo (CH), Italy.
Lorenzo MarchettiDepartment of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti Scalo (CH), Italy.
Majid Sharifi-RadDepartment of Range and Watershed Management, Faculty of Water and Soil, University of Zabol, Zabol 98613-35856, Iran.
Lucia PalumboDepartment of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti Scalo (CH), Italy.ORCID 0000-0002-6206-0266
Francesco EpifanoDepartment of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti Scalo (CH), Italy.ORCID 0000-0002-0381-7812
Serena FioritoDepartment of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti Scalo (CH), Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

7-Isopentenyloxycoumarin is among the most widespread naturally occurring prenyloxy umbelliferone derivatives. This secondary metabolite of mixed biosynthetic origin has been typically isolated from plants belonging to several genera of the Rutaceae and Apiaceae families, comprising widely used medicinal plants and in general plants with beneficial effects on human welfare, as well as edible fruits and vegetables. Although known for quite a long time (more than 50 years), only in the last two decades has this natural compound been revealed to exert powerful and promising pharmacological properties, such as active cancer chemopreventive, antibacterial, antiprotozoal, antifungal, anti-inflammatory, neuroprotective, and antioxidant properties, among the activities best outlined in the recent literature. The aim of this comprehensive miniature review article is to detail the novel natural sources and the effects described during the last decade for 7-isopentenyloxycoumarin and what has been reported on the mechanisms of action underlying the observed biological activities of this oxyprenylated secondary metabolite. In view of the herein described data, suggestions on how to address future research on the abovementioned natural product and structurally related derivatives in the best ways according to the authors will be also provided.

Indexed as

Anti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsApiaceaeCoumarinsHumansNeuroprotective AgentsOxidation-ReductionPlant ExtractsPlants, MedicinalPrenylationRutaceaeSecondary Metabolism7-isopentenyloxycoumarinAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsCoumarinsNeuroprotective AgentsPlant Extracts7-isopentenyloxycoumarinApiaceaeCitruscoumarinsprenylationRutaceae

Identifiers

PMID33327602
PMCPMC7765079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.